BR1733

· Shanghai Blueray Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BR1733, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers [Phase 1, Phase 2]